The research from the FDA Adverse Event Reporting System revealed elevated reporting odds ratios for alopecia with semaglutide (2.46) and tirzepatide (1.73), though notably not with older GLP-1 medications like liraglutide or dulaglutide
A proper GLP-1 evaluation should include: A complete medical history and review of current medications BMI and body composition assessment Blood work including metabolic panel, HbA1c, lipid panel, and thyroid function Cardiovascular risk assessment Discussion of realistic expectations, side effect management, and a plan for nutritional support Be cautious of any service that prescribes GLP-1 medications after a brief online questionnaire with no physician review
GLP-1 medications can be especially relevant in these cases because they affect appetite and glucose-related pathways
Can I drink this warm instead of chilling it
doi: 10.1016/S2213-8587(19)30180-9 10 MarsoSPDanielsGHBrown-FrandsenKKristensenPMannJFNauckMAet al
See website for full details, important safety information, and restrictions, including online provider consultation requirements.
